Advertisement
UK markets open in 3 hours 3 minutes
  • NIKKEI 225

    37,715.25
    -744.83 (-1.94%)
     
  • HANG SENG

    17,294.11
    +92.84 (+0.54%)
     
  • CRUDE OIL

    82.84
    +0.03 (+0.04%)
     
  • GOLD FUTURES

    2,324.30
    -14.10 (-0.60%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • Bitcoin GBP

    51,611.10
    -1,833.62 (-3.43%)
     
  • CMC Crypto 200

    1,391.25
    -32.85 (-2.31%)
     
  • NASDAQ Composite

    15,712.75
    +16.11 (+0.10%)
     
  • UK FTSE All Share

    4,374.06
    -4.69 (-0.11%)
     

Global Blood Glucose Monitoring Systems Industry (2020 to 2027) - Market Trajectory & Analytics

Dublin, April 29, 2021 (GLOBE NEWSWIRE) -- The "Blood Glucose Monitoring Systems - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis, the global market for Blood Glucose Monitoring Systems estimated at US$9.4 Billion in the year 2020, is projected to reach a revised size of US$12.9 Billion by 2027, growing at a CAGR of 4.6% over the period 2020-2027.

Self-Monitoring, one of the segments analyzed in the report, is projected to record 4.6% CAGR and reach US$8.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Continuous segment is readjusted to a revised 4.7% CAGR for the next 7-year period.

The U.S. Market is Estimated at $2.5 Billion, While China is Forecast to Grow at 7.5% CAGR

The Blood Glucose Monitoring Systems market in the U.S. is estimated at US$2.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.7 Billion by the year 2027 trailing a CAGR of 7.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.6% and 3.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Select Competitors (Total 36 Featured):

  • Abbott Laboratories

  • Acon Laboratories

  • Arkray

  • Ascensia Diabetes Care

  • B. Braun Melsungen

  • Dexcom

  • F. Hoffmann-La Roche

  • Lifescan

  • Medtronic

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights

  • World Market Trajectories

  • Impact of Covid-19 and a Looming Global Recession

ADVERTISEMENT

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

  • UNITED STATES

  • CANADA

  • JAPAN

  • CHINA

  • EUROPE

  • FRANCE

  • GERMANY

  • ITALY

  • UNITED KINGDOM

  • SPAIN

  • RUSSIA

  • REST OF EUROPE

  • ASIA-PACIFIC

  • AUSTRALIA

  • INDIA

  • SOUTH KOREA

  • REST OF ASIA-PACIFIC

  • LATIN AMERICA

  • ARGENTINA

  • BRAZIL

  • MEXICO

  • REST OF LATIN AMERICA

  • MIDDLE EAST

  • IRAN

  • ISRAEL

  • SAUDI ARABIA

  • UNITED ARAB EMIRATES

  • REST OF MIDDLE EAST

  • AFRICA

IV. COMPETITION

  • Total Companies Profiled: 36

For more information about this report visit https://www.researchandmarkets.com/r/co0eq2?

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900